| AD | Alzheimer’s disease |
| Aβ | Amyloid beta |
| ALS | Amyotrophic lateral sclerosis |
| BAM | Border-associated macrophage |
| BBB | Blood–brain barrier |
| BCB | Blood–cerebrospinal fluid barrier |
| CD | Cluster of differentiation |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| Dap12 | DNAX activation protein of 12 kDa |
| LGALS9 | Galectin-9 |
| HA | Hyaluronan |
| HMW | High molecular weight |
| HT7R | Hydroxytryptamine Receptor 7 |
| EAE | Experimental autoimmune encephalomyelitis |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EMT | Epithelial-to-mesenchymal transition |
| EAAT | Excitatory amino-acid transporter |
| LPS | Lipopolysaccharide |
| LTP | Long-term potentiation |
| MMP | Matrix metalloproteinase |
| MS | Multiple sclerosis |
| NMJ | Neuromuscular junction |
| NSC | Neural stem cell |
| OPN | Osteopontin |
| OPC | Oligodendrocyte progenitor cell |
| PD | Parkinson’s disease |
| PI3K/AKT | Phosphoinositide 3-kinase/protein kinase B |
| PK | Protein kinase |
| PMCA | Plasma membrane Ca2+ ATPase |
| PNS | Peripheral nervous system |
| RNA-seq | RNA-sequencing |
| SLC7A11 | Cystine/glutamate antiporter xCT |
| SRGN | Serglycin |
| SLYM | Subarachnoid lymphatic-like membrane |
| TEER | Transepithelial electrical resistance |
| TLR4 | Toll-like receptor 4 |
| TREM | Triggering receptor expressed on myeloid |
| VEGF | Vascular endothelial growth factor |